Skip to main content
. Author manuscript; available in PMC: 2017 Sep 25.
Published in final edited form as: Nanotechnology. 2017 Aug 1;28(38):382001. doi: 10.1088/1361-6528/aa8351

Figure 1.

Figure 1

Current clinical treatment options for articular joint damage. Treatment options depend on defect size and severity: (A) defects < 2 cm2; (B) 2 cm2 < defects < 3 cm2; (C) defect ≈ 4 cm2 or multiple defects; (D) end-stage degeneration. Reprinted from [4], Copyright (2010), with permission from Elsevier.